Understanding how to improve antibody responses to Rhinovirus C infections
Mechanisms of Enhanced Neutralizing Antibody Responses to Rhinovirus C
This study is looking into how we can boost the immune response to Rhinovirus C, a virus that often makes young children, especially those with asthma, sick, with the goal of finding better ways to protect them through vaccines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10783774 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind enhanced neutralizing antibody responses to Rhinovirus C, which is a significant cause of respiratory illnesses in young children, particularly those with asthma. The study focuses on understanding the genetic factors that increase susceptibility to Rhinovirus C infections and the potential for developing effective vaccines. By exploring the structure of the virus and the immune response it triggers, the research aims to identify ways to improve vaccine efficacy and provide better protection for at-risk children. The findings could lead to new strategies for preventing and treating Rhinovirus C-related illnesses.
Who could benefit from this research
Good fit: Ideal candidates for this research are young children, particularly those aged 0-11 years, who have a genetic predisposition to Rhinovirus C infections or have a history of asthma.
Not a fit: Patients who are adults or those without a history of respiratory issues or genetic susceptibility to Rhinovirus C may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect children from severe respiratory infections caused by Rhinovirus C.
How similar studies have performed: Previous research has shown promise in developing vaccines for other strains of Rhinovirus, indicating potential for success with similar approaches for Rhinovirus C.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Bochkov, Yury a — University of Wisconsin-Madison
- Study coordinator: Bochkov, Yury a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.